Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 6:41 pm Sale |
2025-03-31 | 13G | Stoke Therapeutics, Inc. STOK |
BLACKROCK INC BLK |
3,118,934 5.800% |
-2,290,235 (-42.34%) |
Filing History |
| 2025-04-15 5:04 pm Purchase |
2025-03-31 | 13G | Stoke Therapeutics, Inc. STOK |
BlackRock Portfolio Management LLC | 2,743,502 5.100% |
2,743,502 (New Position) |
Filing History |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW Investments, LP | 5,310,033 9.990% |
1,178,988 (+28.54%) |
Filing History |
| 2025-02-03 4:36 pm Purchase |
2024-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
MORGAN STANLEY MS |
3,426,739 6.500% |
68,364 (+2.04%) |
Filing History |
| 2024-12-27 5:23 pm Sale |
2024-12-23 | 13D | Stoke Therapeutics, Inc. STOK |
Skorpios Trust | 6,906,181 13.000% |
-2,000,000 (-22.46%) |
Filing History |
| 2024-11-14 9:00 pm Purchase |
2024-09-30 | 13G | Stoke Therapeutics, Inc. STOK |
Redmile Group LLC | 4,713,509 9.000% |
2,088,003 (+79.53%) |
Filing History |
| 2024-11-14 4:24 pm Purchase |
2024-09-30 | 13G | Stoke Therapeutics, Inc. STOK |
Baker Bros. Advisors LP | 4,368,443 8.300% |
4,368,443 (New Position) |
Filing History |
| 2024-11-14 09:00 am Purchase |
2024-09-30 | 13G | Stoke Therapeutics, Inc. STOK |
Lynx1 Capital Management LP | 5,187,191 9.900% |
2,230,273 (+75.43%) |
Filing History |
| 2024-11-12 5:56 pm Unchanged |
2024-09-30 | 13G | Stoke Therapeutics, Inc. STOK |
The Vanguard Group | 2,759,247 5.240% |
0 (Unchanged) |
Filing History |
| 2024-11-04 1:56 pm Purchase |
2024-09-30 | 13G | Stoke Therapeutics, Inc. STOK |
The Vanguard Group | 2,759,247 5.240% |
1,157,202 (+72.23%) |
Filing History |
| 2024-09-23 4:22 pm Sale |
2024-09-19 | 13D | Stoke Therapeutics, Inc. STOK |
Skorpios Trust | 8,906,181 16.900% |
-1,937,500 (-17.87%) |
Filing History |
| 2024-07-08 4:32 pm Purchase |
2024-06-30 | 13G | Stoke Therapeutics, Inc. STOK |
BLACKROCK INC BLK |
5,409,169 10.400% |
5,409,169 (New Position) |
Filing History |
| 2024-04-18 4:18 pm Sale |
2024-04-17 | 13D | Stoke Therapeutics, Inc. STOK |
Skorpios Trust | 10,843,681 23.400% |
-3,600,000 (-24.92%) |
Filing History |
| 2024-02-26 10:38 am Purchase |
2023-12-29 | 13G | Stoke Therapeutics, Inc. STOK |
Cowen Financial Products LLC | 3,721,659 8.300% |
1,445,553 (+63.51%) |
Filing History |
| 2024-02-26 10:36 am Purchase |
2023-01-04 | 13G | Stoke Therapeutics, Inc. STOK |
Cowen Financial Products LLC | 2,276,106 5.770% |
1,028,029 (+82.37%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
Redmile Group LLC | 2,625,506 5.900% |
-1,541,469 (-36.99%) |
Filing History |
| 2024-02-14 09:20 am Purchase |
2023-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
Lynx1 Capital Management LP | 2,956,918 6.600% |
292,760 (+10.99%) |
Filing History |
| 2024-02-14 07:44 am Purchase |
2023-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW Investments, LP | 4,131,045 9.300% |
260,064 (+6.72%) |
Filing History |
| 2024-02-09 2:51 pm Purchase |
2023-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
MORGAN STANLEY MS |
3,358,375 7.500% |
910,161 (+37.18%) |
Filing History |
| 2024-02-09 09:49 am Sale |
2024-02-08 | 13G | Stoke Therapeutics, Inc. STOK |
FMR CORP | 5,000 0.011% |
-3,029,649 (-99.84%) |
Filing History |